1. Development of an Electronic Trigger to Identify Delayed Follow-up HbA1c Testing for Patients with Uncontrolled Diabetes.
- Author
-
Knoll, Brianna, Horwitz, Leora I., Garry, Kira, McCloskey, Jeanne, Nagler, Arielle R., Weerahandi, Himali, Chung, Wei-yi, and Blecker, Saul
- Subjects
GLYCOSYLATED hemoglobin ,PEOPLE with diabetes ,TYPE 2 diabetes ,DYSLIPIDEMIA - Abstract
Diabetes is a major source of morbidity and mortality in the USA with over 1.5 million new cases diagnosed every year.[1] Diabetes is monitored using hemoglobin A1c (HbA1c) as it correlates with burden of disease.[2]-[4] Clinical practice guidelines recommend HbA1c be repeated every 3 months if a patient's value is above 7%, because a higher HbA1c correlates with worse outcomes.[5]-[9] Complications are particularly high in patients with an HbA1c above 10% and even a 1% reduction in HbA1c can reduce complications by 21%.[5] Thus, while regular monitoring of above-goal HbA1c levels is recommended, ensuring patients with an HbA1c over 10% have timely follow-up testing is especially important. Using this trigger, we found that delayed follow-up HbA1c testing is extremely common among those with poorly controlled diabetes, with 45% of patients with an HbA1c over 10% not receiving follow-up testing within 6 months. The initial numerator, representing patients without an appropriate follow-up HbA1c result, was defined as patients without a follow-up clinic visit within 3 months of the index HbA1c test. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF